{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T09:03:47Z","timestamp":1793351027332,"version":"4.5.0"},"reference-count":54,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.vaccine.2016.11.056","type":"journal-article","created":{"date-parts":[[2016,12,26]],"date-time":"2016-12-26T09:51:56Z","timestamp":1482745916000},"page":"345-352","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Beyond expectations: Post-implementation data shows rotavirus vaccination is likely cost-saving in Australia"],"prefix":"10.1016","volume":"35","author":[{"given":"J.F.","family":"Reyes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.G.","family":"Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Beutels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Macartney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"McIntyre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Menzies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Mealing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.T.","family":"Newall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2016.11.056_b0005","unstructured":"World Health Organization. Estimated rotavirus deaths for children under 5 years of age; 2012. Available from: <http:\/\/www.who.int\/immunization\/monitoring_surveillance\/burden\/estimates\/rotavirus\/en\/>."},{"issue":"2","key":"10.1016\/j.vaccine.2016.11.056_b0010","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jhin.2015.12.010","article-title":"Early impact of rotavirus vaccination in a large paediatric hospital in the UK","volume":"93","author":"Hungerford","year":"2016","journal-title":"J Hosp Infect"},{"issue":"7","key":"10.1016\/j.vaccine.2016.11.056_b0015","doi-asserted-by":"crossref","first-page":"532","DOI":"10.4161\/hv.6.7.11278","article-title":"Performance of rotavirus vaccines in developed and developing countries","volume":"6","author":"Jiang","year":"2010","journal-title":"Hum Vaccin"},{"key":"10.1016\/j.vaccine.2016.11.056_b0020","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/1471-2334-13-112","article-title":"The impact of Rotavirus mass vaccination on hospitalization rates, nosocomial Rotavirus gastroenteritis and secondary blood stream infections","volume":"13","author":"Zlamy","year":"2013","journal-title":"BMC Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2016.11.056_b0025","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1097\/INF.0000000000000702","article-title":"Evidence of herd immunity and sustained impact of rotavirus vaccination on the reduction of rotavirus-related medical encounters among infants from 2006 through 2011 in the United States","volume":"34","author":"Mast","year":"2015","journal-title":"Pediatr Infect Dis J"},{"issue":"5","key":"10.1016\/j.vaccine.2016.11.056_b0030","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1111\/j.1467-842X.2006.tb00456.x","article-title":"The burden of rotavirus-related illness among young children on the Australian health care system","volume":"30","author":"Galati","year":"2006","journal-title":"Aust N Z J Public Health"},{"issue":"5","key":"10.1016\/j.vaccine.2016.11.056_b0035","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/j.1440-1754.2010.01953.x","article-title":"Decline in rotavirus hospitalisations following introduction of Australia\u2019s national rotavirus immunisation programme","volume":"47","author":"Macartney","year":"2011","journal-title":"J Paediatr Child Health"},{"issue":"8","key":"10.1016\/j.vaccine.2016.11.056_b0040","doi-asserted-by":"crossref","first-page":"453","DOI":"10.5694\/mja12.10062","article-title":"Changes in hospitalisations for acute gastroenteritis in Australia after the national rotavirus vaccination program","volume":"197","author":"Dey","year":"2012","journal-title":"Med J Aust"},{"issue":"8","key":"10.1016\/j.vaccine.2016.11.056_b0045","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.4161\/hv.24831","article-title":"Impact of rotavirus vaccination in Australian children below 5 years of age: a database study","volume":"9","author":"Pendleton","year":"2013","journal-title":"Hum Vaccin Immunother"},{"issue":"1 Suppl","key":"10.1016\/j.vaccine.2016.11.056_b0050","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1097\/INF.0b013e3181fefdee","article-title":"Reduction in rotavirus-associated acute gastroenteritis following introduction of rotavirus vaccine into Australia\u2019s National Childhood vaccine schedule","volume":"30","author":"Buttery","year":"2011","journal-title":"Pediatr Infect Dis J"},{"issue":"3","key":"10.1016\/j.vaccine.2016.11.056_b0055","doi-asserted-by":"crossref","first-page":"157","DOI":"10.5694\/j.1326-5377.2009.tb02727.x","article-title":"Early evidence for direct and indirect effects of the infant rotavirus vaccine program in Queensland","volume":"191","author":"Lambert","year":"2009","journal-title":"Med J Aust"},{"issue":"2","key":"10.1016\/j.vaccine.2016.11.056_b0060","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/jpc.12098","article-title":"Changes in the epidemiology of gastroenteritis in a paediatric short stay unit following the introduction of rotavirus immunisation","volume":"49","author":"Akikusa","year":"2013","journal-title":"J Paediatr Child Health"},{"issue":"6","key":"10.1016\/j.vaccine.2016.11.056_b0065","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.vaccine.2012.11.099","article-title":"Estimating rotavirus gastroenteritis hospitalisations by using hospital episode statistics before and after the introduction of rotavirus vaccine in Australia","volume":"31","author":"Jayasinghe","year":"2013","journal-title":"Vaccine"},{"issue":"14","key":"10.1016\/j.vaccine.2016.11.056_b0070","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1016\/j.vaccine.2015.01.082","article-title":"Impact of high coverage of monovalent human rotavirus vaccine on Emergency Department presentations for rotavirus gastroenteritis","volume":"33","author":"Davey","year":"2015","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.vaccine.2016.11.056_b0075","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1093\/cid\/cit520","article-title":"Intussusception risk and disease prevention associated with rotavirus vaccines in Australia\u2019s National Immunization Program","volume":"57","author":"Carlin","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"16","key":"10.1016\/j.vaccine.2016.11.056_b0080","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1016\/j.vaccine.2011.01.088","article-title":"Intussusception following rotavirus vaccine administration: post-marketing surveillance in the National Immunization Program in Australia","volume":"29","author":"Buttery","year":"2011","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2016.11.056_b0085","doi-asserted-by":"crossref","first-page":"131","DOI":"10.5694\/j.1326-5377.2009.tb02717.x","article-title":"Rapid impact of rotavirus vaccination in the United States: implications for Australia","volume":"191","author":"Macartney","year":"2009","journal-title":"Med J Aust"},{"key":"10.1016\/j.vaccine.2016.11.056_b0090","unstructured":"Public Summary Document: Rotavirus vaccine, live, oral liquid, pentavalent, 2 mL unit dose, RotaTeq\u00ae. Pharmaceutical Benefits Advisory Committee, July 2006."},{"key":"10.1016\/j.vaccine.2016.11.056_b0095","unstructured":"Public Summary Document: Rotavirus vaccine, live, oral liquid, pentavalent, 2 mL unit dose RotaTeq\u00ae. Pharmaceutical Benefits Advisory Committee, November 2006."},{"issue":"52","key":"10.1016\/j.vaccine.2016.11.056_b0100","doi-asserted-by":"crossref","first-page":"8851","DOI":"10.1016\/j.vaccine.2007.10.009","article-title":"The cost-effectiveness of rotavirus vaccination in Australia","volume":"25","author":"Newall","year":"2007","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2016.11.056_b0105","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/j.1467-842X.1999.tb01546.x","article-title":"Cost effectiveness of rotavirus vaccination in Australia","volume":"23","author":"Carlin","year":"1999","journal-title":"Aust N Z J Public Health"},{"issue":"27","key":"10.1016\/j.vaccine.2016.11.056_b0110","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2016.21.27.30273","article-title":"Sustained low rotavirus activity and hospitalisation rates in the post-vaccination era in Belgium","volume":"21","author":"Sabbe","year":"2016","journal-title":"Eurosurveillance"},{"issue":"7","key":"10.1016\/j.vaccine.2016.11.056_b0115","doi-asserted-by":"crossref","first-page":"734","DOI":"10.4161\/hv.7.7.15511","article-title":"Summary of effectiveness and impact of rotavirus vaccination with the oral pentavalent rotavirus vaccine: a systematic review of the experience in industrialized countries","volume":"7","author":"Giaquinto","year":"2011","journal-title":"Hum Vaccin"},{"issue":"3","key":"10.1016\/j.vaccine.2016.11.056_b0120","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.vaccine.2015.11.053","article-title":"Retrospective economic evaluation of childhood 7-valent pneumococcal conjugate vaccination in Australia: uncertain herd impact on pneumonia critical","volume":"34","author":"Newall","year":"2016","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.vaccine.2016.11.056_b0125","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.vaccine.2013.11.067","article-title":"Economic evaluations of implemented vaccination programmes: key methodological challenges in retrospective analyses","volume":"32","author":"Newall","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.11.056_b0130","unstructured":"Guidelines for the Pharmaceutical Industry on Preparation of Submissions to the Pharmaceutical Benefits Advisory Committee (PBAC) Version 4.4. 2013, C.D.o.H.a. Ageing, Editor., Commonwealth Department of Health and Ageing."},{"key":"10.1016\/j.vaccine.2016.11.056_b0135","unstructured":"Australian Demographic Statistics, Estimated Resident Population by Single Year of Age, Australia (ABS catalogue number: 3101.0). Australian Bureau of Statistics: Canberra; 2009."},{"key":"10.1016\/j.vaccine.2016.11.056_b0140","unstructured":"National Hospital Cost Data Collection: Public Sector - Estimated Round 12 (2007\u201308) AR-DRG 5.1 Cost Report; 2008."},{"key":"10.1016\/j.vaccine.2016.11.056_b0145","unstructured":"National Hospital Cost Data Collection: Private Sector - National Consolidated Cost Weights Round 12 (2007\u201308) AR-DRG 5.1 Cost Report; 2008."},{"key":"10.1016\/j.vaccine.2016.11.056_b0150","unstructured":"Medicare Benefits Schedule (MBS) [cited 2015 October 2015]; Available from: <http:\/\/www.mbsonline.gov.au\/internet\/mbsonline\/publishing.nsf\/Content\/Home>."},{"key":"10.1016\/j.vaccine.2016.11.056_b0155","unstructured":"James ML. Budget Review 2007\u20132008: Science, Technology, Environment and Resources Section. Parliament of Australia; 2008."},{"issue":"1","key":"10.1016\/j.vaccine.2016.11.056_b0160","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/INF.0b013e3181b41506","article-title":"Health-related quality of life lost to rotavirus-associated gastroenteritis in children and their parents: a Canadian prospective study","volume":"29","author":"Brisson","year":"2010","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2016.11.056_b0165","doi-asserted-by":"crossref","unstructured":"Bilcke Joke, Beutels P, De Smet Frank, Hanquet Germaine, Van Ranst Marc, Van Damme Pierre. Cost-effectiveness analysis of rotavirus vaccination of Belgian infants; 2007.","DOI":"10.57598\/R54C"},{"issue":"7","key":"10.1016\/j.vaccine.2016.11.056_b0170","doi-asserted-by":"crossref","first-page":"e68482","DOI":"10.1371\/journal.pone.0068482","article-title":"Childhood intussusception: a literature review","volume":"8","author":"Jiang","year":"2013","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1016\/j.vaccine.2016.11.056_b0175","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa052434","article-title":"Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis","volume":"354","author":"Ruiz-Palacios","year":"2006","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.vaccine.2016.11.056_b0180","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.vaccine.2009.10.041","article-title":"RotaTeq, a pentavalent rotavirus vaccine: efficacy and safety among infants in Europe","volume":"28","author":"Vesikari","year":"2009","journal-title":"Vaccine"},{"issue":"48","key":"10.1016\/j.vaccine.2016.11.056_b0185","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2015.20.48.30077","article-title":"Assessing the impacts of the first year of rotavirus vaccination in the United Kingdom","volume":"20","author":"Marlow","year":"2015","journal-title":"Euro Surveill"},{"issue":"3","key":"10.1016\/j.vaccine.2016.11.056_b0190","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1093\/cid\/cir307","article-title":"Direct and indirect effects of rotavirus vaccination upon childhood hospitalizations in 3 US Counties, 2006\u20132009","volume":"53","author":"Payne","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"1 Suppl","key":"10.1016\/j.vaccine.2016.11.056_b0195","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1097\/INF.0b013e3181fefdc0","article-title":"Uptake, impact, and effectiveness of rotavirus vaccination in the United States: review of the first 3 years of postlicensure data","volume":"30","author":"Tate","year":"2011","journal-title":"Pediatr Infect Dis J"},{"issue":"11","key":"10.1016\/j.vaccine.2016.11.056_b0200","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1086\/652403","article-title":"Reduction in acute gastroenteritis hospitalizations among US children after introduction of rotavirus vaccine: analysis of hospital discharge data from 18 US states","volume":"201","author":"Curns","year":"2010","journal-title":"J Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2016.11.056_b0205","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1097\/INF.0b013e3181d95b53","article-title":"Reduction in gastroenteritis in United States children and correlation with early rotavirus vaccine uptake from national medical claims databases","volume":"29","author":"Cortese","year":"2010","journal-title":"Pediatr Infect Dis J"},{"issue":"1","key":"10.1016\/j.vaccine.2016.11.056_b0210","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1542\/peds.2010-1393","article-title":"Diarrhea-associated hospitalizations among US children over 2 rotavirus seasons after vaccine introduction","volume":"127","author":"Yen","year":"2011","journal-title":"Pediatrics"},{"issue":"13","key":"10.1016\/j.vaccine.2016.11.056_b0215","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1016\/j.vaccine.2011.12.002","article-title":"Report of the second European expert meeting on rotavirus vaccination","volume":"30","author":"Giaquinto","year":"2012","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2016.11.056_b0220","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1007\/s00431-013-1945-3","article-title":"Major reduction of rotavirus, but not norovirus, gastroenteritis in children seen in hospital after the introduction of RotaTeq vaccine into the National Immunization Programme in Finland","volume":"172","author":"Hemming","year":"2013","journal-title":"Eur J Pediatr"},{"issue":"7","key":"10.1016\/j.vaccine.2016.11.056_b0225","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1093\/infdis\/jir492","article-title":"Infant rotavirus vaccination may provide indirect protection to older children and adults in the United States","volume":"204","author":"Lopman","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2016.11.056_b0230","unstructured":"Centers for Disease Control and Prevention. Delayed onset and diminished magnitude of rotavirus activity--United States, November 2007\u2013May 2008. MMWR Morb Mortal Wkly Rep 2008; 57(25): 697\u2013700."},{"issue":"9","key":"10.1016\/j.vaccine.2016.11.056_b0235","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1136\/emermed-2014-204174","article-title":"Age before acuity: the drivers of demand for emergency department services in the Greater Sydney Area","volume":"32","author":"Dinh","year":"2015","journal-title":"Emerg Med J"},{"issue":"4","key":"10.1016\/j.vaccine.2016.11.056_b0240","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/1742-6723.12250","article-title":"Demand for emergency department services in the elderly: an 11 year analysis of the Greater Sydney Area","volume":"26","author":"Leonard","year":"2014","journal-title":"Emerg Med Austral"},{"issue":"8","key":"10.1016\/j.vaccine.2016.11.056_b0245","doi-asserted-by":"crossref","first-page":"e42320","DOI":"10.1371\/journal.pone.0042320","article-title":"Direct and indirect effects of rotavirus vaccination: comparing predictions from transmission dynamic models","volume":"7","author":"Pitzer","year":"2012","journal-title":"PLoS ONE"},{"issue":"27","key":"10.1016\/j.vaccine.2016.11.056_b0250","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.1016\/j.vaccine.2016.04.014","article-title":"Assessing the impact of vaccination programmes on burden of disease: underlying complexities and statistical methods","volume":"34","author":"Mealing","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.11.056_b0255","unstructured":"Country introductions of rotavirus vaccines [30 April 2016]. <http:\/\/sites.path.org\/rotavirusvaccine\/country-introduction-maps-and-spreadsheet\/>."},{"issue":"6","key":"10.1016\/j.vaccine.2016.11.056_b9005","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.jpedsurg.2011.03.034","article-title":"Intussusception in children: cost-effectiveness of ultrasound vs diagnostic contrast enema","volume":"46","author":"Bucher","year":"2011","journal-title":"J Pediatr Surg"},{"issue":"1","key":"10.1016\/j.vaccine.2016.11.056_b9010","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1056\/NEJMoa052664","article-title":"Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine","volume":"354","author":"Vesikari","year":"2006","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.vaccine.2016.11.056_b9015","doi-asserted-by":"crossref","first-page":"e6060","DOI":"10.1371\/journal.pone.0006060","article-title":"Estimating the incidence of symptomatic rotavirus infections: a systematic review and meta-analysis","volume":"4","author":"Bilcke","year":"2009","journal-title":"PLoS One"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16311185?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16311185?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:23:41Z","timestamp":1759400621000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X16311185"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":54,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["S0264410X16311185"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.11.056","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Beyond expectations: Post-implementation data shows rotavirus vaccination is likely cost-saving in Australia","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.11.056","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}